Recordati SpA (RCDTF)
58.00
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Recordati EPS Diluted (Quarterly) : 0.6511 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6511 |
| March 31, 2026 | 0.8564 |
| December 31, 2025 | 0.653 |
| September 30, 2025 | 0.6159 |
| June 30, 2025 | 0.4931 |
| March 31, 2025 | 0.6294 |
| December 31, 2024 | 0.3989 |
| September 30, 2024 | 0.5932 |
| June 30, 2024 | 0.5243 |
| March 31, 2024 | 0.6414 |
| December 31, 2023 | 0.4355 |
| September 30, 2023 | 0.4003 |
| June 30, 2023 | 0.5387 |
| March 31, 2023 | 0.6363 |
| December 31, 2022 | 0.3458 |
| September 30, 2022 | 0.4339 |
| June 30, 2022 | 0.2788 |
| March 31, 2022 | 0.5183 |
| December 31, 2021 | 0.4904 |
| September 30, 2021 | 0.5033 |
| June 30, 2021 | 0.6752 |
| March 31, 2021 | 0.5179 |
| December 31, 2020 | 0.4614 |
| September 30, 2020 | 0.4313 |
| June 30, 2020 | 0.4515 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.5861 |
| December 31, 2019 | 0.61 |
| September 30, 2019 | 0.4225 |
| June 30, 2019 | 0.4416 |
| March 31, 2019 | 0.4996 |
| December 31, 2018 | 0.4074 |
| September 30, 2018 | 0.4094 |
| June 30, 2018 | 0.4418 |
| March 31, 2018 | 0.5088 |
| December 31, 2017 | 0.3885 |
| September 30, 2017 | 0.4088 |
| June 30, 2017 | 0.3613 |
| March 31, 2017 | 0.3997 |
| December 31, 2016 | 0.2834 |
| September 30, 2016 | 0.3181 |
| June 30, 2016 | 0.3094 |
| March 31, 2016 | 0.3451 |
| December 31, 2015 | 0.243 |
| September 30, 2015 | 0.2612 |
| June 30, 2015 | 0.2721 |
| March 31, 2015 | 0.2788 |
| December 31, 2014 | 0.2223 |
| September 30, 2014 | 0.265 |
| June 30, 2014 | 0.2619 |
| March 31, 2014 | 0.2768 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Avadel Pharmaceuticals Plc | 0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 135.59M |
| Revenue (Quarterly) | 810.82M |
| Total Expenses (Quarterly) | 675.23M |
| Enterprise Value | 14.07B |
| Gross Profit Margin (Quarterly) | 71.41% |
| Profit Margin (Quarterly) | 16.72% |
| Earnings Yield | 4.79% |
| Operating Earnings Yield | 7.78% |
| Normalized Earnings Yield | 5.096 |